A detailed history of Canada Pension Plan Investment Board transactions in Biogen Inc. stock. As of the latest transaction made, Canada Pension Plan Investment Board holds 173,664 shares of BIIB stock, worth $30.2 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
173,664
Previous 109,159 59.09%
Holding current value
$30.2 Million
Previous $23.5 Million 71.04%
% of portfolio
0.04%
Previous 0.03%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$190.52 - $236.72 $12.3 Million - $15.3 Million
64,505 Added 59.09%
173,664 $40.3 Million
Q1 2024

May 14, 2024

BUY
$212.02 - $267.71 $685,460 - $865,506
3,233 Added 3.05%
109,159 $23.5 Million
Q4 2023

Feb 14, 2024

SELL
$222.59 - $267.94 $31 Million - $37.3 Million
-139,284 Reduced 56.8%
105,926 $27.4 Million
Q3 2023

Nov 09, 2023

BUY
$253.3 - $285.89 $23.4 Million - $26.4 Million
92,400 Added 60.47%
245,210 $63 Million
Q2 2023

Aug 09, 2023

SELL
$275.25 - $318.06 $4.4 Million - $5.09 Million
-16,000 Reduced 9.48%
152,810 $43.5 Million
Q1 2023

May 12, 2023

BUY
$256.56 - $292.34 $2.93 Million - $3.34 Million
11,415 Added 7.25%
168,810 $46.9 Million
Q4 2022

Feb 14, 2023

SELL
$252.44 - $306.72 $15.9 Million - $19.3 Million
-62,860 Reduced 28.54%
157,395 $43.6 Million
Q3 2022

Nov 14, 2022

BUY
$194.69 - $268.46 $24 Million - $33.1 Million
123,400 Added 127.41%
220,255 $58.8 Million
Q2 2022

Aug 12, 2022

SELL
$187.54 - $223.02 $4.43 Million - $5.26 Million
-23,600 Reduced 19.59%
96,855 $19.8 Million
Q1 2022

May 13, 2022

SELL
$193.77 - $244.14 $23.6 Million - $29.7 Million
-121,674 Reduced 50.25%
120,455 $25.4 Million
Q4 2021

Feb 14, 2022

SELL
$223.92 - $287.77 $5.98 Million - $7.68 Million
-26,686 Reduced 9.93%
242,129 $58.1 Million
Q3 2021

Nov 15, 2021

BUY
$282.99 - $369.05 $7.79 Million - $10.2 Million
27,525 Added 11.41%
268,815 $76.1 Million
Q2 2021

Aug 16, 2021

SELL
$259.0 - $414.71 $902,356 - $1.44 Million
-3,484 Reduced 1.42%
241,290 $83.6 Million
Q1 2021

May 17, 2021

BUY
$242.95 - $284.63 $55.7 Million - $65.3 Million
229,464 Added 1498.79%
244,774 $68.5 Million
Q4 2020

Feb 17, 2021

SELL
$236.26 - $355.63 $6.36 Million - $9.57 Million
-26,923 Reduced 63.75%
15,310 $3.75 Million
Q3 2020

Nov 12, 2020

SELL
$264.77 - $305.71 $6.33 Million - $7.31 Million
-23,924 Reduced 36.16%
42,233 $12 Million
Q2 2020

Aug 14, 2020

SELL
$258.66 - $342.55 $3.07 Million - $4.07 Million
-11,875 Reduced 15.22%
66,157 $17.7 Million
Q1 2020

May 13, 2020

SELL
$268.85 - $341.04 $18.2 Million - $23.1 Million
-67,848 Reduced 46.51%
78,032 $24.7 Million
Q4 2019

Feb 14, 2020

SELL
$220.06 - $304.07 $68.6 Million - $94.7 Million
-311,580 Reduced 68.11%
145,880 $43.3 Million
Q3 2019

Nov 12, 2019

BUY
$217.44 - $243.88 $12.5 Million - $14 Million
57,570 Added 14.4%
457,460 $107 Million
Q2 2019

Aug 12, 2019

SELL
$219.29 - $241.72 $780,672 - $860,523
-3,560 Reduced 0.88%
399,890 $93.5 Million
Q1 2019

May 15, 2019

BUY
$216.71 - $338.96 $12.6 Million - $19.8 Million
58,314 Added 16.9%
403,450 $95.4 Million
Q4 2018

Feb 06, 2019

SELL
$278.5 - $352.75 $44.5 Million - $56.4 Million
-159,782 Reduced 31.65%
345,136 $104 Million
Q3 2018

Nov 09, 2018

BUY
$293.51 - $383.83 $98.5 Million - $129 Million
335,481 Added 198.0%
504,918 $178 Million
Q2 2018

Aug 07, 2018

SELL
$257.52 - $306.91 $88 Million - $105 Million
-341,694 Reduced 66.85%
169,437 $49.2 Million
Q1 2018

May 14, 2018

BUY
$260.13 - $367.91 $67.3 Million - $95.1 Million
258,600 Added 102.4%
511,131 $140 Million
Q4 2017

Feb 14, 2018

SELL
$307.64 - $344.58 $34.4 Million - $38.5 Million
-111,700 Reduced 30.67%
252,531 $80.4 Million
Q3 2017

Oct 30, 2017

BUY
$281.15 - $329.69 $2.11 Million - $2.47 Million
7,500 Added 2.1%
364,231 $114 Million
Q2 2017

Jan 31, 2018

BUY
N/A
119,000 Added 50.06%
356,731 $96.8 Million
Q1 2017

Jan 31, 2018

BUY
N/A
237,731
237,731 $65 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Canada Pension Plan Investment Board Portfolio

Follow Canada Pension Plan Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on Canada Pension Plan Investment Board with notifications on news.